Quadrant Capital Group’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-521
Closed -$2K 2781
2022
Q3
$2K Buy
+521
New +$2K ﹤0.01% 2380
2022
Q1
Sell
-52
Closed 2576
2021
Q4
$0 Buy
+52
New ﹤0.01% 2589
2021
Q3
Sell
-33
Closed -$1K 2558
2021
Q2
$1K Buy
+33
New +$1K ﹤0.01% 2278